Product Code: ETC332665 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Thailand Meningococcal Vaccines Market focuses on vaccines specifically designed to protect against meningococcal disease, which can lead to severe bacterial infections like meningitis and septicemia. These vaccines are an essential part of Thailand`s immunization program, especially for children and adolescents. Public health initiatives and government vaccination campaigns play a significant role in ensuring access to meningococcal vaccines. Ongoing research and development efforts contribute to the availability of improved and more effective vaccines.
The Thailand Meningococcal Vaccines market is primarily driven by the growing awareness of the potentially life-threatening nature of meningococcal diseases. The Thai government`s emphasis on public health and vaccination programs has significantly increased vaccination rates. Parents and healthcare professionals are increasingly recognizing the importance of protecting children and adolescents against meningococcal infections. The rise in international travel and the risk of imported cases have also prompted greater interest in meningococcal vaccines. Furthermore, advancements in vaccine development and distribution networks have made these vaccines more accessible to the general population, contributing to market growth.
The Thailand Meningococcal Vaccines Market faces challenges in vaccine development and public awareness. Meningococcal diseases are relatively rare, making it challenging to justify the development of vaccines. Public education campaigns are needed to raise awareness about the severity of these diseases and the importance of vaccination.
The Thailand Meningococcal Vaccines Market saw a significant impact during the COVID-19 pandemic. With the focus primarily on COVID-19 vaccines, routine immunization schedules for other diseases, including meningococcal vaccines, were disrupted. Additionally, travel restrictions and reduced international tourism affected the demand for certain vaccines. Vaccination campaigns faced challenges in reaching the target population due to lockdowns and social distancing measures. As the situation normalizes, the market is expected to rebound, especially with renewed emphasis on vaccine-preventable diseases.
In the Thailand Meningococcal Vaccines market, several key players have established their presence. Companies like Sanofi Pasteur, GlaxoSmithKline (GSK), Pfizer, and Merck are among the leading players. These pharmaceutical giants are at the forefront of vaccine development and distribution in Thailand. Their extensive research and development capabilities, coupled with a strong distribution network, have allowed them to offer a wide range of meningococcal vaccines to meet the country`s healthcare needs. Additionally, local players such as Siam Bioscience have also made significant strides in the market, contributing to the availability and accessibility of meningococcal vaccines for the Thai population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Meningococcal Vaccines Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Meningococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Meningococcal Vaccines Market - Industry Life Cycle |
3.4 Thailand Meningococcal Vaccines Market - Porter's Five Forces |
3.5 Thailand Meningococcal Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Thailand Meningococcal Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 Thailand Meningococcal Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Meningococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of meningococcal vaccines in Thailand |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing prevalence of meningococcal disease in the region |
4.3 Market Restraints |
4.3.1 High cost associated with meningococcal vaccines |
4.3.2 Limited accessibility to vaccines in rural areas of Thailand |
4.3.3 Potential side effects and safety concerns related to vaccines |
5 Thailand Meningococcal Vaccines Market Trends |
6 Thailand Meningococcal Vaccines Market, By Types |
6.1 Thailand Meningococcal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Thailand Meningococcal Vaccines Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Thailand Meningococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021-2031F |
6.1.4 Thailand Meningococcal Vaccines Market Revenues & Volume, By Conjugate, 2021-2031F |
6.2 Thailand Meningococcal Vaccines Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 Thailand Meningococcal Vaccines Market Revenues & Volume, By Infants, 2021-2031F |
6.2.3 Thailand Meningococcal Vaccines Market Revenues & Volume, By Children, 2021-2031F |
6.2.4 Thailand Meningococcal Vaccines Market Revenues & Volume, By Adolescents & Young Adults, 2021-2031F |
6.2.5 Thailand Meningococcal Vaccines Market Revenues & Volume, By Adults, 2021-2031F |
6.3 Thailand Meningococcal Vaccines Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Thailand Meningococcal Vaccines Market Revenues & Volume, By Pharmacies, 2021-2031F |
6.3.3 Thailand Meningococcal Vaccines Market Revenues & Volume, By Community Clinics, 2021-2031F |
6.3.4 Thailand Meningococcal Vaccines Market Revenues & Volume, By Public Health Agencies, 2021-2031F |
6.3.5 Thailand Meningococcal Vaccines Market Revenues & Volume, By Others, 2021-2031F |
7 Thailand Meningococcal Vaccines Market Import-Export Trade Statistics |
7.1 Thailand Meningococcal Vaccines Market Export to Major Countries |
7.2 Thailand Meningococcal Vaccines Market Imports from Major Countries |
8 Thailand Meningococcal Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rate for meningococcal vaccines in Thailand |
8.2 Number of meningococcal disease cases reported annually |
8.3 Rate of adoption of new and advanced meningococcal vaccines in the market |
9 Thailand Meningococcal Vaccines Market - Opportunity Assessment |
9.1 Thailand Meningococcal Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Thailand Meningococcal Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 Thailand Meningococcal Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Meningococcal Vaccines Market - Competitive Landscape |
10.1 Thailand Meningococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Thailand Meningococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |